About GENFO Bioceuticals
GENFO Bioceuticals is a Healthcare company. It operates as a pharmaceutical and bioceuticals manufacturing focused on innovative healthcare solutions. The company has 33 employees. Its Indian entity Genfo Bioceuticals Private Limited reported revenue of ₹7.68 Cr. GENFO Bioceuticals offers products and services including Cardiac Products and Gynaecology and Infertility Products. Its focus areas include Pharmaceuticals, Drug Manufacturing, Bioceuticals Development and Manufacturing.
Company details
GENFO Bioceuticals is recognized for reimagining medicine to enhance and prolong lives through the application of innovative science and technology. Breakthrough treatments are discovered and developed to tackle significant healthcare challenges, with new delivery methods being explored for broader accessibility. The company is associated with leading manufacturing entities that hold USFDA approval and WHO-GMP certification, ensuring high standards. Advanced technologies like BIOSYS are employed to surpass conventional dosing requirements, while a commitment to quality is integrated across operations. Products span multiple segments, supporting global access to advanced bioceuticals, with growth driven by innovation and expertise.
- Employees 33
- SectorsHealthcare
- Email••••••••
- Social Facebook Instagram YouTube
- Legal Name Genfo Bioceuticals Pvt Ltd
- Date of Incorporation 04 Sep, 2013
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹7.68 Cr
FY 2024 · +11% YoY
- Net Profit₹20.5 Lakh
FY 2024 · 3% margin
- EBITDA₹71.4 Lakh
FY 2024 · 9% margin
- Employee Count33
Associated legal entities of GENFO Bioceuticals
GENFO Bioceuticals operates through Genfo Bioceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genfo Bioceuticals Private Limited CIN U51909TG2013PTC089846 | Active | 04 Sep 2013 | Hyderabad, Telangana | ₹7.7 Cr | 33 | 2 | View details |
Products & Services of GENFO Bioceuticals
GENFO Bioceuticals offers a comprehensive portfolio of products and services, including Cardiac Products and Gynaecology and Infertility Products.
Products for cardiac health are developed and distributed through various segments.
Products for gynaecology and infertility are provided as part of the medicinal offerings.
Apps and channels of GENFO Bioceuticals
its YouTube channel Genfo Bioceuticals Pvt Ltd has 65 subscribers and 5 videos.
Videos from GENFO Bioceuticals
The most watched videos on GENFO Bioceuticals's YouTube channel, Genfo Bioceuticals Pvt Ltd (65 subscribers). Click a video to play it here.
More on Genfo Bioceuticals Pvt Ltd.
Board of directors of Genfo Bioceuticals Private Limited (GENFO Bioceuticals)
Genfo Bioceuticals Private Limited is the primary company behind GENFO Bioceuticals. The board of Genfo Bioceuticals Private Limited currently have 2 directors; the longest-serving is Rajeshwasr Reddy Ganta, appointed in 2013.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajeshwasr Reddy Ganta DIN 06513469 | Director | 04 Sep 2013 | 13 yrs 1 mo | Genfo Bioceuticals Private Limited |
| Neeraja Ganta DIN 06513463 | Director | 04 Sep 2013 | 13 yrs 1 mo | Genfo Bioceuticals Private Limited |
Financials of GENFO Bioceuticals
Figures of Genfo Bioceuticals Private Limited, the primary company behind GENFO Bioceuticals, for FY 2024. Revenue was ₹7.68 Cr (+11% year on year). Net profit was ₹20.5 Lakh (3% margin). EBITDA was ₹71.4 Lakh (9% margin). Revenue has grown at a compounded annual rate of +15% over three years and +5% over five years.
- ₹7.68 CrRevenue · FY 2024 · +11% YoY
- ₹20.5 LakhNet profit · 3% margin
- ₹71.4 LakhEBITDA · 9% margin
- ₹15 LakhPaid-up capital
- 33Employees (provident fund records)
- +15%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Genfo Bioceuticals Private Limited are on its company page.
Detailed financial statements for GENFO Bioceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as GENFO Bioceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GENFO Bioceuticals
GENFO Bioceuticals has 33 employees.
The primary company behind GENFO Bioceuticals, Genfo Bioceuticals Private Limited, reported revenue of ₹7.68 Cr for FY 2024, up 11% year on year.
GENFO Bioceuticals is recognized for reimagining medicine to enhance and prolong lives through the application of innovative science and technology. Breakthrough treatments are discovered and developed to tackle significant healthcare challenges, with new delivery methods being explored for broader accessibility. The company is associated with leading manufacturing entities that hold USFDA approval and WHO-GMP certification, ensuring high standards. Advanced technologies like BIOSYS are employed to surpass conventional dosing requirements, while a commitment to quality is integrated across operations. Products span multiple segments, supporting global access to advanced bioceuticals, with growth driven by innovation and expertise.
GENFO Bioceuticals offers Cardiac Products and Gynaecology and Infertility Products.
GENFO Bioceuticals operates through Genfo Bioceuticals Private Limited.
The legal entities of GENFO Bioceuticals currently have 2 directors, including Rajeshwasr Reddy Ganta, Neeraja Ganta.